1/14
04:02 am
txmd
TherapeuticsMD (NASDAQ:TXMD) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Low
Report
TherapeuticsMD (NASDAQ:TXMD) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
12/23
04:14 pm
txmd
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
12/2
03:46 pm
txmd
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
01:58 pm
txmd
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
TherapeuticsMD (NASDAQ:TXMD) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
04:05 pm
txmd
TherapeuticsMD Announces Third Quarter 2025 Financial Results
Low
Report
TherapeuticsMD Announces Third Quarter 2025 Financial Results